STOCK TITAN

Issuer (NASDAQ: FATE) holder to sell 5,190 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder has filed a notice of intent to sell 5,190 shares of common stock through Fidelity Brokerage Services LLC on or about 01/09/2026, with trading on the NASDAQ exchange. The shares have an aggregate market value of $5,557.45 based on the information provided and are part of a total of 115,352,289 shares outstanding. These securities were acquired from the issuer on 01/08/2026 through restricted stock vesting as compensation, with the same date shown for acquisition and payment.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144-related filing for FATE indicate?

It indicates that a shareholder plans to sell 5,190 shares of common stock on NASDAQ through Fidelity Brokerage Services LLC, with an aggregate market value of $5,557.45.

How many FATE shares are planned to be sold and on which exchange?

The notice covers 5,190 shares of common stock, with trading indicated for the NASDAQ exchange.

When and how were the FATE shares to be sold originally acquired?

The 5,190 shares were acquired on 01/08/2026 from the issuer through restricted stock vesting as compensation.

What is the reported market value of the FATE shares covered by this notice?

The filing lists an aggregate market value of $5,557.45 for the 5,190 common shares to be sold.

How many FATE shares are outstanding according to this filing excerpt?

The table states that there are 115,352,289 shares of the issuer’s common stock outstanding.

Who is the broker for the planned FATE share sale?

The notice identifies Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, as the broker.
Fate Therapeutic

NASDAQ:FATE

FATE Rankings

FATE Latest News

FATE Latest SEC Filings

FATE Stock Data

121.12M
113.60M
1.71%
78.68%
8.37%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SAN DIEGO